Back to News
Market Impact: 0.35

ACN Factor-Based Stock Analysis

ACNNDAQ
Company FundamentalsAnalyst InsightsCorporate EarningsCapital Returns (Dividends / Buybacks)Technology & Innovation
ACN Factor-Based Stock Analysis

Validea's guru fundamental report highlights Accenture PLC (ACN) with an 85% rating from its 'Patient Investor' model, based on Warren Buffett's strategy. This indicates strong underlying fundamentals and a reasonable valuation for the large-cap Computer Services growth stock, driven by its predictable profitability, low debt, robust free cash flow, and strong returns on equity and capital. The high rating suggests ACN is a compelling consideration for long-term, value-oriented investors seeking fundamentally sound companies.

Analysis

Accenture PLC (ACN) receives a strong endorsement from Validea's 'Patient Investor' fundamental report, scoring 85% based on a model emulating Warren Buffett's investment strategy. This high rating, which approaches the model's threshold for strong interest, is underpinned by the company's robust financial health and predictable operations. The analysis indicates ACN passes critical tests for earnings predictability, debt service capacity, and free cash flow generation. Furthermore, the firm demonstrates superior profitability, meeting criteria for high return on equity and return on total capital, as well as efficient use of retained earnings. While its share repurchase activity is rated as neutral, the overall assessment points to a large-cap growth company in the Computer Services sector that possesses the durable competitive advantages and reasonable valuation sought by long-term, value-oriented investors.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo